Literature DB >> 23054972

Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Li Wang1, Douglas H Sweet.   

Abstract

Organic solute flux across the basolateral and apical membranes of renal proximal tubule cells is a key process for maintaining systemic homeostasis. It represents an important route for the elimination of metabolic waste products and xenobiotics, as well as for the reclamation of essential compounds. Members of the organic anion transporter (OAT, SLC22) family expressed in proximal tubules comprise one pathway mediating the active renal secretion and reabsorption of organic anions. Many drugs, pesticides, hormones, heavy metal conjugates, components of phytomedicines, and toxins are OAT substrates. Thus, through transporter activity, the kidney can be a target organ for their beneficial or detrimental effects. Detailed knowledge of the OATs expressed in the kidney, their membrane targeting, substrate specificity, and mechanisms of action is essential to understanding organ function and dysfunction. The intracellular processes controlling OAT expression and function, and that can thus modulate kidney transport capacity, are also critical to this understanding. Such knowledge is also providing insight to new areas such as renal transplant research. This review will provide an overview of the OATs for which transport activity has been demonstrated and expression/function in the kidney observed. Examples establishing a role for renal OATs in drug clearance, food/drug-drug interactions, and renal injury and pathology are presented. An update of the current information regarding the regulation of OAT expression is also provided.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054972      PMCID: PMC3535093          DOI: 10.1208/s12248-012-9413-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  107 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 2.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

3.  Stability and biotransformation of various dietary anthocyanins in vitro.

Authors:  Jens Fleschhut; Frank Kratzer; Gerhard Rechkemmer; Sabine E Kulling
Journal:  Eur J Nutr       Date:  2005-04-18       Impact factor: 5.614

4.  Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions.

Authors:  Min-Koo Choi; Qing-Ri Jin; Yeong-Lim Choi; Sung-Hoon Ahn; Myung-Ae Bae; Im-Sook Song
Journal:  Biopharm Drug Dispos       Date:  2011-02-24       Impact factor: 1.627

5.  In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna.

Authors:  M J Cutler; B L Urquhart; T J Velenosi; H E Meyer Zu Schwabedissen; G K Dresser; B F Leake; R G Tirona; R B Kim; D J Freeman
Journal:  J Clin Pharmacol       Date:  2011-04-19       Impact factor: 3.126

6.  Antioxidant activities, total phenolics and HPLC analyses of the phenolic compounds of extracts from common Mediterranean plants.

Authors:  Taha M Rababah; Khalil I Ereifej; Ranya B Esoh; Muhammad H Al-u'datt; Mohammad A Alrababah; W Yang
Journal:  Nat Prod Res       Date:  2011-03       Impact factor: 2.861

7.  The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1.

Authors:  Alexander C Whitley; Douglas H Sweet; Thomas Walle
Journal:  Drug Metab Dispos       Date:  2005-05-03       Impact factor: 3.922

8.  Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.

Authors:  Carl Kyrklund; Janne T Backman; Mikko Neuvonen; Pertti J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2003-06       Impact factor: 6.875

9.  Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.

Authors:  U Jaehde; F Sörgel; A Reiter; G Sigl; K G Naber; W Schunack
Journal:  Clin Pharmacol Ther       Date:  1995-11       Impact factor: 6.875

10.  Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8).

Authors:  Li Wang; Douglas H Sweet
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-15       Impact factor: 2.629

View more
  41 in total

1.  Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009-2014.

Authors:  Franco Scinicariello; Melanie C Buser; Lina Balluz; Kimberly Gehle; H Edward Murray; Henry G Abadin; Roberta Attanasio
Journal:  Chemosphere       Date:  2020-06-20       Impact factor: 7.086

Review 2.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 3.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

4.  Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.

Authors:  Zhibo Gai; Michele Visentin; Christian Hiller; Evelin Krajnc; Tongzhou Li; Junhui Zhen; Gerd A Kullak-Ublick
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 5.  Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.

Authors:  Aniv Mann; Inessa Semenenko; Michal Meir; Sara Eyal
Journal:  AAPS J       Date:  2015-03-31       Impact factor: 4.009

Review 6.  Loops and layers of post-translational modifications of drug transporters.

Authors:  Da Xu; Guofeng You
Journal:  Adv Drug Deliv Rev       Date:  2016-05-09       Impact factor: 15.470

7.  Cumulative organic anion transporter-mediated drug-drug interaction potential of multiple components in salvia miltiorrhiza (danshen) preparations.

Authors:  Li Wang; Jürgen Venitz; Douglas H Sweet
Journal:  Pharm Res       Date:  2014-06-25       Impact factor: 4.200

8.  Flavonoids are inhibitors of human organic anion transporter 1 (OAT1)-mediated transport.

Authors:  Guohua An; Xiaodong Wang; Marilyn E Morris
Journal:  Drug Metab Dispos       Date:  2014-07-07       Impact factor: 3.922

9.  Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.

Authors:  Xiaolei Pan; Li Wang; Dirk Gründemann; Douglas H Sweet
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

Review 10.  Posttranslational Regulation of Organic Anion Transporters by Ubiquitination: Known and Novel.

Authors:  Da Xu; Haoxun Wang; Guofeng You
Journal:  Med Res Rev       Date:  2016-06-12       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.